These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3875968)

  • 1. Problems in the detection of complement-fixing immune complexes.
    Rødahl E
    Acta Pathol Microbiol Immunol Scand C; 1985 Jun; 93(3):125-30. PubMed ID: 3875968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays.
    Davey MP; Korngold L
    Int Arch Allergy Appl Immunol; 1982; 67(3):278-83. PubMed ID: 6977496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
    Olds LC; Miller JJ
    Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of circulating immune complexes in patients with ankylosing spondylitis.
    Maksymowych W; Dasgupta MK; Rothwell RS; Dossetor JB; Russell AS
    Rheumatol Int; 1981; 1(3):107-9. PubMed ID: 6981182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The measurement of IgG class circulating immune complexes in liver diseases using F(ab')2 anti C3 ELISA].
    Muratsugu M; Makino M; Kohda H; Sekiya C
    Rinsho Byori; 1987 Dec; 35(12):1385-91. PubMed ID: 3502152
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of solid phase Clq and horseradish peroxidase-conjugated goat anti-IgG for the detection of immune complexes in human serum.
    Wehler C; Andrews JM; Bing DH
    Mol Immunol; 1981 Mar; 18(3):157-62. PubMed ID: 6973690
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients.
    Moore TL; Dorner RW
    Rheumatol Int; 1986; 6(2):49-52. PubMed ID: 3532285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating antigen-antibody complexes in onchocerciasis.
    Steward MW; Sisley B; Mackenzie CD; El Sheikh H
    Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of circulating immune complex levels by ELISA using F(ab')2 anti-C3 antibody].
    Muratsugu M; Makino M
    Rinsho Byori; 1986 Oct; Spec No 69():53-9. PubMed ID: 3806992
    [No Abstract]   [Full Text] [Related]  

  • 13. Modified anti-C3 immune complex assay which avoids interference by anti-F(ab')2 antibodies.
    Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1985 Jul; 146(3):337-47. PubMed ID: 3931296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clq binding activity of monomeric IgG].
    Uwatoko S; Aotsuka S; Okawa M; Yokohari R; Aizawa C; Suzuki K
    Arerugi; 1982 Oct; 31(10):1022-8. PubMed ID: 6984822
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis.
    Elson CJ; Scott DG; Blake DR; Bacon PA; Holt PD
    Ann Rheum Dis; 1983 Apr; 42(2):147-50. PubMed ID: 6601932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis.
    Duquesnoy B; Santoro F; Wattre P; Delcambre B
    Ann Rheum Dis; 1980 Oct; 39(5):449-52. PubMed ID: 6969066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the recommended use of anti-Clq for reducing non-specific reactions in solid-phase C1q assays for circulating immune complexes.
    Wainer EM; Schepers G; Schweizer K; Pusztai-Markos Z
    J Immunol Methods; 1984 Jan; 66(1):193-5. PubMed ID: 6363550
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of immune complex-like material in sera of patients with paraproteinaemia.
    Klein F; Lafeber GJ; Jongepier-Geerdes YE; Cats A; Kauffmann RH; Michiels JJ
    J Clin Pathol; 1981 Sep; 34(9):1036-9. PubMed ID: 7276217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.